4 reports

  • 2.2 EUROPE - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES
  • 7.5 INCREASING AWARENESS ON SEASONAL INFLUENZA & VACCINATION

The vaccination coverage rate is given below: FORECAST 2011 - ## 2012 - ##. ## 2013 - ##. ## 2014 - ##. ## 2015 - ##. ## 2016 - ##. ## FIGURE ##-##: GERMANY - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES (MILLION), 2011 - 2015 2017 - ##. ## 2018 - ##. ## 2019 - ##. ## 2020 - ##. ## 2021 - ##. ##

  • Influenza
  • Europe
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Infectious Disease
  • Influenza
  • Medical Biotechnology
  • Europe
  • Demand

MARKET ##.

  • Influenza
  • Therapy
  • Vaccine
  • Europe
  • World
  • AUG 08, 2018: FIRST PARTICIPANT ENROLLED IN BIONDVAX'S UNIVERSAL FLU VACCINE PIVOTAL PHASE 3 CLINICAL TRIAL
  • AUG 10, 2018: BIONDVAX ENROLS FIRST PATIENT IN PHASE LLL TRIAL OF M-001

These participants will be monitored for one flu season.

  • Influenza
  • Vaccine
  • Europe
  • Company
  • BiondVax Pharmaceuticals Ltd.